Understand the source comparison
Cycling vs continuous use
Some peptides benefit from cycling, periods of use alternating with periods off. Others work best with continuous administration. Understanding which approach suits each peptide helps design optimal long-term protocols. Peptides favoring cycling: Epithalon wor
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Some peptides benefit from cycling, periods of use alternating with periods off. Others work best with continuous administration. Understanding which approach suits each peptide helps design optimal long-term protocols.
- Peptides favoring cycling: Epithalon works best in 10-20 day bursts, 2-3 cycles per year. Continuous use may reduce effectiveness through receptor downregulation. Some GH secretagogues show reduced effectiveness over months of continuous use, though this is debated.
- Peptides suitable for continuous use: BPC-157 shows stable effectiveness with long-term use, no significant tolerance development. Semaglutide and other GLP-1 agonists are designed for continuous use, maintaining effectiveness indefinitely. TB-500 can be used continuously at maintenance doses after initial loading.